Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-012942

Principal Accounting Officer gave up 1,016 shares (to pay taxes)

  • Principal Accounting Officer acquired 3,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Alenson Carman Principal Accounting Officer 2019-02-21 Option exercise +3,300 3,812 D
Alenson Carman Principal Accounting Officer 2019-02-21 Shares withheld for taxes −1,016 $56.33 $57,231 2,796 D
Derivatives
Alenson Carman Principal Accounting Officer 2019-02-21 Option exercise · Restricted stock units −3,300 0 D
Loading xslF345X03/doc4.xml…